Scientific Health Development Partners

Profile

Scientific Health Development (SHD) is a venture capital firm based in Dallas, Texas, founded in 2006 by Philip Romano and Stuart Fitts. The firm specializes in early-stage investments in the medtech sector, focusing on innovative medical technologies that address unmet clinical needs. SHD's team includes Andrew Offer, who joined in 2007, bringing expertise in healthcare valuation and reimbursement analysis. The firm prides itself on its strategic approach and productive relationships with portfolio companies.

SHD invests primarily in early-stage medtech companies within the United States, targeting technologies that improve patient outcomes and reduce economic burdens. The firm typically invests in companies requiring smaller funding amounts with near-term value inflection points. SHD offers a unique investment opportunity to its limited partners, leveraging Qualified Small Business tax advantages and shielding investments from public market volatility. The firm manages multiple fund portfolios, including Scientific Health Development II, Ltd., with an AUM of $15 million launched in 2018.

Notable investments by SHD include the Palmaz stent, which revolutionized the coronary stent market. The firm continues to focus on medtech innovations, maintaining a niche in the healthcare investment landscape.